Contact this trialFirst, we need to learn more about you.
Antiretroviral
Dolutegravir/Rilpivirine FDC for Human Immunodeficiency Virus Infection
Recruiting1 awardPhase 1 & 2
Washington, District of Columbia
This trial aims to gather information on how well a new 2-drug combination tablet works in children aged 6 to 12 years who have HIV and have their viral levels under control.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.